Signals → ABEO
SEC Filing Analysis

ABEO — Complete Signal History

Every significant change detected in ABEO's SEC filings by Tracenotes — language shifts, financial anomalies, and risk signals across all analyzed 10-K and 10-Q filings.

1
Filings analyzed
1
High signals
0
Medium signals
0
Low signals
Signal Timeline
High10-KRegulatory

Abeona has achieved FDA approval for ZEVASKYN, its gene therapy for rare skin disease RDEB, marking a transition from clinical dev...

2026-03-17
View →
Analyze Any Filing Free

See what changed in ABEO's latest filing

500+ S&P 500 companies analyzed. Enter any ticker for instant analysis.

Analyze ABEO free →
Other Companies Analyzed
LADRLADLACLABLKODKKODKO